跳至主要内容
临床试验/ISRCTN11319909
ISRCTN11319909已完成2 期

Examining the role of Early Neoadjuvant and Synchronous Erbitux in Preoperative Chemo-Radiotherapy using Xeloda followed by Excisional Surgery

niversity College London (UK)0 个研究点目标入组 22 人开始时间: 2010年5月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adenocarcinoma of the rectum (within 15 cm of anal verge)
  • 2. Tumour tissue available for testing of epidermal growth factor receptor (EGFR) status
  • 3. Indication for pre-operative chemoradiotherapy with R0 resection unlikely
  • 4. Fit for chemotherapy
  • 5. Written informed consent for both treatment and biopsies
  • 6. Male and female, lower age limit of 18 years

排除标准

  • 1. Previous radiotherapy to the pelvis
  • 2. Previous pelvic resectional surgery (cystectomy, hysterectomy)
  • 3. Previous chemotherapy or radiation for rectal cancer
  • 4. Previous chemotherapy for metastatic disease
  • 5. Patients who have very significant small bowel delineated within the radiation fields
  • 6. Currently enrolled in any other treatment trial

研究者

发起方
niversity College London (UK)

相似试验